IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2014 Holdings

Filed 2015-02-17 | 16 holdings | $2.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ANI Pharmaceuticals Inc(ANIP)COM00182C103$1.7M31,00086.2%
Ariad Pharmaceuticals IncCOM04033A100$88.3K12,850,0004.4%
Quest Diagnostics Inc(DGX)COM74834L100$52.0K775,0002.6%
Amgen Inc(AMGN)COM031162100$50.7K318,0002.5%
Merck & Co Inc New(MRK)COM58933Y105$22.7K400,0001.1%
Agilent Technologies Inc.(A)COM00846U101$18.8K460,0000.9%
Bio-Reference Labs IncCOM $.01 NEW09057G602$12.5K390,2700.6%
Repros Therapeutics IncCOM NEW76028H209$11.3K1,132,3670.6%
Vivus IncCOM928551100$7.4K2,573,9430.4%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$6.4K360,0000.3%
Kindred Biosciences IncCOM494577109$5.1K689,0910.3%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.2K2,570,7590.1%
Targacept IncCOM87611R306$1.7K630,0000.1%
Apricus Biosciences IncCOM03832V109$1.0K1,030,0000.1%
Eleven Biotherapeutics Inc.COM286221106$48941,2000.0%
Cyclacel Pharmaceuticals Inc.COM NEW23254L306$263376,0000.0%